Fu Yu, Chen Dongjia, Cai Bing, Xu Yan, Zhu Shuhua, Ding Chenhui, Wang Yali, Wang Jing, Li Rong, Guo Jing, Pan Jiafu, Zeng Yanhong, Zhong Yiping, Shen Xiaoting, Zhou Canquan
Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong 510080, PR China; Guangdong Provincial Key Laboratory of Reproductive Medicine, Guangzhou Guangdong 510080, PR China; The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou HainanGuangdong 570102, PR China.
Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong 510080, PR China; Guangdong Provincial Key Laboratory of Reproductive Medicine, Guangzhou Guangdong 510080, PR China.
Reprod Biomed Online. 2022 Feb;44(2):239-246. doi: 10.1016/j.rbmo.2021.09.009. Epub 2021 Sep 20.
Which of the two mainstream endometrial preparation regimens, assisted natural cycle (NC) or hormone replacement treatment cycle (HRT), help frozen-thawed embryo transfer (FET) cycles after preimplantation genetic testing (PGT) achieve better clinical outcomes?
This retrospective analysis included 3400 vitrified-warmed single blastocyst transfer cycles after PGT from January 2011 to November 2020, and involved 2332 patients with regular menstrual cycles. The decision to proceed with an assisted NC (n = 827) or HRT (n = 2573) before FET was reached based on a combination of patient preference and physician guidance. Clinical pregnancy rate, live birth rate, early miscarriage rate and obstetric outcomes were compared.
No significant difference was observed between the assisted NC and HRT groups in terms of clinical pregnancy rate (51.6% versus 50.7%, P = 0.634), live birth rate (44.0% versus 43.4%, P = 0.746) or early miscarriage rate (12.6% versus 12.0%, P = 0.707). Multivariate analysis indicated that the endometrial preparation protocol was not an independent factor for a clinical pregnancy or live birth. In the HRT group, the Caesarean section rate (64.7% versus 51.9%, P < 0.001) and pregnancy complication rate (20.2% versus 13.8%, P = 0.003) were significantly higher. The two groups were not statistically different with respect to gestational age, early preterm birth rate, fetal weight or fetal birth defect rate.
For patients undergoing a PGT-FET cycle involving a single blastocyst transfer, using assisted NC and HRT for the endometrial preparation could lead to comparable rates of clinical pregnancy and live birth. Additionally, NC is safer than HRT in terms of avoiding pregnancy complications and adverse obstetric outcomes.
在植入前基因检测(PGT)后的冻融胚胎移植(FET)周期中,两种主流的子宫内膜准备方案,即辅助自然周期(NC)和激素替代治疗周期(HRT),哪一种能带来更好的临床结局?
这项回顾性分析纳入了2011年1月至2020年11月期间PGT后3400个玻璃化冷冻复苏单囊胚移植周期,涉及2332名月经周期规律的患者。在FET前进行辅助自然周期(n = 827)或激素替代治疗(n = 2573)的决定是基于患者偏好和医生指导共同做出的。比较了临床妊娠率、活产率、早期流产率和产科结局。
辅助自然周期组和激素替代治疗组在临床妊娠率(51.6%对50.7%,P = 0.634)、活产率(44.0%对43.4%,P = 0.746)或早期流产率(12.6%对12.0%,P = 0.707)方面未观察到显著差异。多因素分析表明,子宫内膜准备方案不是临床妊娠或活产的独立因素。在激素替代治疗组中,剖宫产率(64.7%对51.9%,P < 0.001)和妊娠并发症发生率(20.2%对13.8%,P = 0.003)显著更高。两组在孕周、早期早产率、胎儿体重或胎儿出生缺陷率方面无统计学差异。
对于接受单囊胚移植的PGT-FET周期患者,使用辅助自然周期和激素替代治疗进行子宫内膜准备可导致相似的临床妊娠率和活产率。此外,在避免妊娠并发症和不良产科结局方面,自然周期比激素替代治疗更安全。